We are representing victims in California and throughout the country who suffered side effects such as Nephrogenic Systemic Fibrosis (NSF) after they were injected with a gadolinium-based contrast agent before an MRI. The purpose of the contrast agent was to clarify the MRI image so the MRI can be read more accurately. Since 2011, there have been published reported side effects of the risks of Gadolinium retention.
In 2015, the FDA published its first of many safety warnings regarding Gadolinium. Gadolinium is a toxic chemical. Unfortunately, Gadolinium does not leave the body as quickly as the drug manufacturers represented. It remains in the body for a much longer period of time. Patients are therefore at risk of suffering from excess Gadolinium.
Gadolinium Side Effects
Nephrogenic Systemic Fibrosis
Nephrogenic Systemic Fibrosis (NSF) is renal (kidney) insufficiency due to gadolinium retention. The retention causes kidney problems including thickening and darkening of the skin, shortening of the muscles and tendons and other similar symptoms. It is an extremely serious condition. If you or a loved one has suffered from this condition please have them contact our offices.
Gadolinium Deposition Disease
This is when a person, prior to the gadolinium injection has normal kidney functioning but after being injected develops painful symptoms in their kidney areas. Gadolinium retention can also cause significant pain in the arms and legs, bone pain, tissue burning, and similar injuries. This is called Gadolinium Deposition Disease. The symptoms must occur within two months of the injection. Many doctors are not aware of this diagnosis or condition. If you or a loved one have these symptoms after receiving gadolinium injection dye, please contact our offices. We are actively handling these cases throughout the country.
Manufacturers of Gadolinium Dye
|Bayer||Magnevist and Eovist|
For years, the FDA has issued various Public Health Advisories warning doctors, manufacturers and the public of the link between Gadolinium-enhanced MRI scans and patients diagnosed with Nephrogenic Systemic Fibrosis. We are actively handling these claims in California and nationwide. We intend to prove that the manufacturers did not adequately test their products for side effects including NSF nor warn patients of the length of time Gadolinium actually remains in the body.
In March 2017, The European Medicines Agency (EMA) recommend linear Gadolinium agents be removed from the market, including Multihance, Optimark, Omniscan, and Magnevist.
California Gadolinium Lawyers
We and our partners have been filing gadolinium side effect lawsuits against all responsible manufacturers. We believe patients were not properly warned of the risks associated with Gadolinium. Patients were led to believe that Gadolinium would soon leave the body but that is not true. Gadolinium is retained in the body for lengthy periods of time and can cause Gadolinium toxicity or Nephrogenic Systemic Fibrosis.
How We Can Help
We are gadolinium side effect attorneys and are representing clients and their loved ones throughout the country. We will protect your legal rights. Please contact one of our experienced gadolinium intake staff members who will answer your questions and provide you with the resources you need to know more about the injuries you suffered and how we can obtain compensation for you.
Who Is Nadrich & Cohen, LLP?
Nadrich & Cohen, LLP is one of the largest California personal injury law firms with offices throughout the state. Our attorneys are experienced in going up against large corporations and pharmaceutical companies. Our legal teams can successfully handle your case. We have ample resources to take on any defendant. Let us and our partners help. We have cases throughout the country. Please read our reviews.
We are contingency lawyers who represent gadolinium dye side effect clients on a contingency basis. This means we advance all the costs, expenses and fees until we obtain a recovery. If we do not obtain a recovery you owe us nothing for our time, costs, expenses or fees.
Request A Free Case Evaluation
Call us today at 1-800-718-4658 or complete the “Do I Have a Case” questionnaire on the right. We will be in touch with you within 24 hours.
1. What is Gadolinium?
Gadolinium is a rare earth metal that is silvery-white in appearance. Gadolinium is often used in radiography because when used as a metal or salt, it absorbs neutrons. As a phosphor, gadolinium is used in imaging. It emits green light, making it very useful for enhancing the imaging quality of X-rays.
2. What are Gadolinium Side Effects?
Gadolinium has been known to remain in the body after an MRI or X-ray. As a result, it can lead to side effects. Gadolinium can lead to two major medical conditions: nephrogenic systemic fibrosis and gadolinium deposition disease. They can cause kidney failure, darkened skin, shortening of muscles and tendons, bone pain, and pain in the arms and legs.
3. How long does it take for gadolinium to leave your system?
Gadolinium leaves the body via urine output. For those with normal kidney function, the elimination half-life of gadolinium is about two hours. Therefore, it should fully leave your body within four hours.
4. Has the FDA recalled Gadolinium MRI Contrast Dye Agents?
In December 2017, the FDA required a new class warning for contrast agents containing gadolinium. There is concern about gadolinium remaining in patients’ brains and other parts of the body for months to years. However, the use of gadolinium MRI contrast dye agents continues to outweigh any potential risks. The FDA has not recalled these contrast agents at this time.
There are a few requirements, however. Manufacturers must alert health care professionals and patients about the risk of gadolinium retention. Patients must be given a medication guide, which provides educational information. Manufacturers of gadolinium due agents must also conduct human and animal studies to further assess safety.
Europe, however, has taken a stricter approach. The government has suspended and recalled gadodiamide and intravenous gadopentetic acid. Other types of contrast agents are being used on a limited basis only.
5. Are all MRI contrast dye agents unsafe?
No. Health issues such as gadolinium deposition disease have only been linked to linear formulations of gadolinium dye. Other MRI contrast dye agents are safe to use.
6. What is Gadolinium Deposition Disease (GDD)?
Gadolinium deposition disease (GDD) is a condition that causes those with normal renal function to suddenly develop a variety of symptoms caused by an immune response. Those with a genetic abnormality are most likely to suffer from GDD.
The symptoms include bone pain, burning pain in the tissues and a degree of mental confusion described as “brain fog.” As GDD progresses, it causes skin to thicken and change color. Pain in the arms and legs can also develop. The symptoms can begin within hours, days or even months from the time the person is exposed to gadolinium.
7. How Is Gadolinium Deposition Disease diagnosed?
While blood tests may be used to diagnose gadolinium deposition disease, they are not the most reliable. A 24-hour urine test is the most frequently used.
8. What treatments are available for Gadolinium Deposition Disease?
There are a couple ways in which a person can treat gadolinium deposition disease. Medication such as antihistamines and anti-inflammatories can reduce the severity of symptoms. Immune system therapy and re-chelation are two effective therapies. Targeted host-immune-modulator agents can also be helpful for some.
9. Can I File a Lawsuit for Gadolinium Toxicity?
If you began to suffer from gadolinium deposition disease symptoms shortly after an MRI, you may be eligible for compensation for your damages. Patients have not been properly warned about the risks of gadolinium MRI contrast dyes. Due to this lack of warning, you may be able to hold the manufacturer responsible.
Contact Nadrich & Cohen, LLP to discuss your case by calling 1-800-718-4658, using the live chat feature or completing the “Do I Have A Case?” form on this page.